Xilio Therapeutics Revenue and Competitors

Boston, MA USA

Location

$233M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Xilio Therapeutics's estimated annual revenue is currently $16.1M per year.(i)
  • Xilio Therapeutics's estimated revenue per employee is $169,684
  • Xilio Therapeutics's total funding is $233M.
  • Xilio Therapeutics's current valuation is $398.8M. (January 2022)

Employee Data

  • Xilio Therapeutics has 95 Employees.(i)
  • Xilio Therapeutics grew their employee count by -10% last year.

Xilio Therapeutics's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
VP, Head Investor Relations & Corporate CommunicationsReveal Email/Phone
3
VP, Head Human ResourcesReveal Email/Phone
4
SVP Clinical OperationsReveal Email/Phone
5
VP, Drug DiscoveryReveal Email/Phone
6
VP Translational SciencesReveal Email/Phone
7
SVP Program Leadership and RegulatoryReveal Email/Phone
8
VP BiologicsReveal Email/Phone
9
SVP, ITReveal Email/Phone
10
VP, Commercial Strategy and PlanningReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5.2M67-45%$107.3MN/A
#2
$0.3M20%N/AN/A
#3
$5.1M336%N/AN/A
#4
$11.9M77-37%$312.8MN/A
#5
$0.9M60%N/AN/A
#6
$235M300-5%$340.9MN/A
#7
$45.9M237-7%$7.6MN/A
#8
$3.9M5035%N/AN/A
#9
$5.4M353%N/AN/A
#10
$1.6M100%N/AN/A
Add Company

What Is Xilio Therapeutics?

Xilio is a Waltham, Massachusetts-based biopharmaceutical company focused on defeating cancer. The company?s proprietary technology enables the explosion of therapeutic activity specifically within the tumor while reducing toxicity throughout the body ? a nod to the company name, Xilio, derived from the Latin term, Ex Nihilo, meaning creation or big-bang. Xilio is applying its technology to build a broad pipeline of engineered antibodies, cytokines and chemokines as potential new options for people living with cancer. To learn more, please visit www.xiliotx.com.

keywords:N/A

$233M

Total Funding

95

Number of Employees

$16.1M

Revenue (est)

-10%

Employee Growth %

$398.8M

Valuation

N/A

Accelerator

Xilio Therapeutics News

2022-04-20 - Insights on the Targeted Therapy Global Market to 2028 ...

Most types of targeted therapies help to treat cancer by ... For instance, Xilio Therapeutics, a biotechnology company entered into a...

2022-04-06 - Xilio Therapeutics Inc's Lock-Up Period Set To End on April ...

Xilio Therapeutics' (NASDAQ:XLO – Get Rating) lock-up period is set to end ... Xilio Therapeutics had issued 7,353,000 shares in its IPO on...

2022-03-30 - Werewolf cancer drug strikes right note with Jazz Pharma ...

Xilio Therapeutics aims to improve on cytokine safety with a “mask” that stays on the therapy until it reaches the tumor microenvironment.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$13.9M967%N/A
#2
$14.9M9622%N/A
#3
$16.4M989%$129.3M
#4
$13.3M994%N/A
#5
$28.7M9962%N/A